NCPDP (National Council for Prescription Drug Programs, Inc.)’s Post

I am profoundly grateful for the opportunity to engage in a Good Clinical Practice (#GCP) #certification🧾 course in #association🤝 with the National Institute on Drug Abuse (#NIDA), the National Institutes of Health (#NIH), and the Clinical Trial Network (#CTN), which play a crucial role in assessing the impacts of #drugs💊 and #medicaldevices🔬 on #human🧑🦱 subjects. This experience has #equipped🛠️ me with essential #knowledge💡 and #skills🛠️, particularly in adhering to the rigorous standards of Good Clinical Practice (#GCP). Completing the #GCP training and committing to ongoing #education🎩 every 3️⃣ years has #fortified🍃 my understanding of the #ethical✅ and #safety⛑️ considerations vital to conducting #clinicaltrials🧪. Additionally, my involvement with the Human Subjects System (#HSS) has been #instrumental in #streamlining the management of #clinicaltrial data and enhancing #collaboration🤝 among #investigators and #NIH staff. I take #pride😇 in knowing that my work contributes to a #transparent and #accountable #research🔬 environment, ensuring that all #trials🧪 are accurately #registered📝 and #reported⌨️ on 👇 www.ClinicalTrials.gov Through this journey, I have developed a deeper appreciation for the #responsibilities that come with being a #clinicaltrial🧪 #investigator🕵️. The training I received has #empowered me to uphold the #rights✊ and #safety⛑️ of #human🧑🦱 subjects while ensuring the #integrity and #reliability of #trialdata📝. I am #honored☺️ to have #achieved🗂️ high marks and maintained #confidentiality in all aspects of the #clinicaltrial🧪 protocol, as recognized by the Institutional Review Board (#IRB). This experience has not only shaped my #professional🤵 development but has also instilled a profound sense of #purpose in my contributions to #oncology🦀 #research🔬. #oncology #medicalresearch #clinicaltrial #IRB #safety #protocol #NIH #NIDA #HSS #Precisionmedicine #Treatment

VCT has cross-sponsor capabilities to detect duplicate research participants & "professional participants" within clinical trials and our ability to prevent this from happening at screening.    Detection of "professional" & duplicate participants is a key driver of RBQM activities. Detection is beneficial but by that time, it's too late. The participant has been enrolled, dosed, must be dropped, re-recruited, etc. It's a significant waste of time & money and risk to patient safety & data quality.   Our value is in our ability to prevent duplicate/professional participants from enrolling into a study by implementing the safeguards (VCT) at screening, thus enhancing data quality, integrity, and patient safety. The protections continue the entire duration of the study. #verifiedclincialtrials #professionalsubjects

RPS Advanced Pharmacy Framework vs US Marine Standards: A Critical Comparison

I am excited to share that I have successfully completed the Good Clinical Practice (GCP) Certification. This program, funded by the National Institute on Drug Abuse (NIDA) under the National Institutes of Health (NIH) provided comprehensive knowledge in key areas such as: • Informed consent • Participant safety and adverse events • Institutional review boards • Research protocols, documentation, and quality assurance Clinical research plays an important role in advancing medical science, upholding ethical standards, and prioritizing patient safety. This certification reaffirms my commitment to these principles and to making meaningful contributions in public health and clinical research. #ClinicalResearch #GoodClinicalPractice #PublicHealth #EthicalResearch #ProfessionalDevelopment #NIH #HealthResearch #safety

📢𝐍𝐚𝐯𝐢𝐠𝐚𝐭𝐢𝐧𝐠 𝐄𝐭𝐡𝐢𝐜𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐌𝐒𝐋 𝐑𝐨𝐥𝐞. 𝐌𝐚𝐤𝐢𝐧𝐠 𝐭𝐡𝐞 𝐑𝐢𝐠𝐡𝐭 𝐂𝐡𝐨𝐢𝐜𝐞𝐬.📢 Ethical considerations are crucial for MSLs as they balance industry objectives with patient care, ensuring trust and integrity. By prioritizing patient safety, maintaining transparency, and avoiding conflicts of interest, MSLs can build trust, uphold the highest standards of integrity, and make a lasting positive impact on the healthcare community. 📍 Patient First: Prioritize patient well-being in all interactions. 📍 Compliance: Stay aligned with industry regulations and guidelines. 📍 Transparency: Maintain honesty and transparency in your communication. Master Ethical Decision-Making – Learn More with MSL Academy 🔗themslacademy.com #MSLCommunication #MedicalAffairs #StakeholderEngagement #Pharma #MSLCommunity #MSL #TheMSLAcademy

I'm thrilled to share that I have successfully completed the Good Clinical Practice (GCP) course through the NIDA Clinical Trials Network. This comprehensive training covered essential topics such as informed consent, confidentiality, participant safety, research protocol, and more. Understanding these critical aspects of clinical research is vital to ensuring ethical and high-quality outcomes. This certification enhances my ability to contribute effectively to research initiatives, particularly in healthcare, where precision and adherence to protocols are paramount. Looking forward to applying this knowledge to drive impactful and compliant research projects in the future! #ClinicalResearch #GoodClinicalPractice #HealthcareInnovation #ResearchEthics

"I'm thrilled to share that I've completed the Certificate of Completion in Good Clinical Practice through the NIDA Clinical Trials Network! This comprehensive six-hour course has equipped me with essential knowledge in critical areas like Institutional Review Boards, Informed Consent, Participant Safety, and Quality Assurance. I'm committed to upholding the highest standards in clinical research and grateful for the opportunity to enhance my skills. Thanks to the National Institute on Drug Abuse, National Institutes of Health, for funding this training. I'm excited to apply my knowledge and contribute to advancing clinical research! #GoodClinicalPractice #ClinicalResearch #NIDA #CTN #CertificateOfCompletion"

Verónica Del Carmen Nateras, GMDP Academy alumna, dives deep into the transformative power of purpose, asking: 'What if aligning your professional identity with your values could reshape not just your career, but the future of medicines development?' Her thought-provoking essay invites us to reimagine impact through purpose. #gmdpacademy #medicalaffairs #medicinesdevelopment #professionalidentity #continuingeducation

🔎 An interesting read: "Pharmacy users’ perceptions, awareness and future expectations of community pharmacy in England: a focus group study"

Excited to share that I've successfully completed the rigorous NIDA Clinical Trials Network certificate program! 🎓 Throughout this comprehensive course, I've delved deep into the intricate world of clinical research, gaining invaluable insights into pivotal aspects such as informed consent, confidentiality, and participant safety. 🔍💡 Exploring topics ranging from quality assurance to documentation and record-keeping, I've honed my understanding of the meticulous processes essential for conducting ethical and impactful research. 📝Armed with a solid grasp of investigational new drugs and roles/responsibilities within the clinical trial landscape, I'm poised to contribute meaningfully to advancing healthcare innovation. 💉 With a firm commitment to upholding the highest standards of research integrity, I'm eager to leverage this newfound knowledge to drive forward groundbreaking studies while prioritizing participant well-being. 🌟 Excited for the journey ahead and the opportunities to make a tangible difference in healthcare! #ClinicalTrials #ResearchExcellence #HealthcareInnovation"